Recorded Chinese product: 吡嗪酰胺片吡嗪酰胺片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 重庆迪康长江制药有限公司Chinese legal name: 重庆迪康长江制药有限公司
主要成分Active Ingredients
- 吡嗪酰胺Biqin Xianan
药物知识说明
吡嗪酰胺是一种在国家药监局注册认定的药品。该药品含有吡嗪酰胺-b0c70c44等成分。
该药品关联的活性成分包括：吡嗪酰胺Biqin Xianan。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：重庆迪康长江制药有限公司Chinese legal name: 重庆迪康长江制药有限公司。
您可以探索含有相同成分的其他药品：吡嗪酰胺-b0c70c44成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 吡嗪酰胺片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 吡嗪酰胺Biqin Xianan.
Manufacturers recorded for this product: 重庆迪康长江制药有限公司Chinese legal name: 重庆迪康长江制药有限公司.
Explore other medicines containing the same ingredient: 吡嗪酰胺 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 吡嗪酰胺片Recorded Chinese product: 吡嗪酰胺片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.25g0.25 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 重庆迪康长江制药有限公司Chinese legal name: 重庆迪康长江制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H50021361
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H50021361
Manufacturer
Chinese legal name: 重庆迪康长江制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H50021361
生产企业
重庆迪康长江制药有限公司(国产)
适应症
本品仅对分枝杆菌有效，与其他抗结核药(如链霉素、异烟肼、利福平及乙胺丁醇)联合用于治疗结核病。
用法用量
口服。 1.成人常用量，与其他抗结核药联合，每日15～30mg/kg顿服，或50～70mg/kg，每周2～3次。 2.每日服用者最高每日2g，每周3次者最高每次3g，每周服2次者最高每次4g。
不良反应
1.发生率较高者:关节痛(由于高尿酸血症引起，常轻度，有自限性)。
2.发生率较少者:食欲减退、发热、乏力或软弱、眼或皮肤黄染(肝毒性)，畏寒。
禁忌
对本品过敏者禁用。
注意事项
1.交叉过敏，对乙硫异烟胺、异烟肼、烟酸或其他化学结构相似的药物过敏患者可能对本品也过敏。
2.对诊断的干扰：本品可与硝基氰化钠作用产生红棕色，影响尿酮测定结果;可使丙氨酸氨基转移酶、门冬氨酸氨基转移酶、血尿酸浓度测定值增高。
3.糖尿病、痛风或严重肝功能减退者慎用。
4.应用本品疗程中血尿酸常增高，可引起急性痛风发作，须进行血清尿酸测定。
5.本品亦可采用间歇给药法，每周用药2次，每次50mg/kg。
贮藏
遮光，密闭保存。
规格
0.25g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.